Current Research in Therapeutic Targets

Alzheimer's disease (AD) as of now exhibits one of the greatest medicinal services issues in the created nations. There is no successful treatment equipped for backing off infection movement. As of late the fundamental concentrate of research on novel pharmacotherapies depended on the amyloidogenic speculation of AD, which places that the beta amyloid (Aβ) peptide is primarily in charge of subjective hindrance and neuronal demise. The objective of such medicines is (a) to diminish Aβ creation through the restraint of β and γ secretase chemicals and (b) to advance disintegration of existing cerebral Aβ plaques. Be that as it may, this approach has turned out to be just unobtrusively viable. Late investigations propose an option methodology fixated on the restraint of the downstream Aβ flagging, especially at the neural connection. Aβ oligomers may cause deviant N-methyl-D-aspartate receptor (NMDAR) initiation postsynaptically by shaping buildings with the phone surface prion protein (PrPC). PrPC is enhanced at the neuronal postsynaptic thickness, where it collaborates with Fyn tyrosine kinase. Fyn enactment happens when Aβ is bound to PrPC-Fyn complex. Fyn causes tyrosine phosphorylation of the NR2B subunit of metabotropic glutamate receptor 5 (mGluR5). Fyn kinase blockers masitinib and saracatinib have ended up being effective in treating AD side effects in trial mouse models of the illness.

 

  • Amyloid Plaques
  • Loss of Neuronal Connections and Cell Death
  • Vascular Contributions to Alzheimer’s Disease

Related Conference of Current Research in Therapeutic Targets

September 04-05, 2025

10th Annual Neurologists and Neurosurgeons Meet

Vancouver, Canada
September 15-16, 2025

39th European Neurology Congress

Paris, France
September 25-26, 2025

12th Annual congress on Stroke and Neurological Disorders

Zurich, Switzerland
October 17-18, 2025

5th International Conference on Child Neurology

London, UK
October 20-21, 2025

20th Annual Congress on Neuroscience

Paris, France
October 20-21, 2025

7th World Brain Congress

Osaka, Japan
October 23-24, 2025

8th Global Congress on Spine and Spinal Disorders

London, UK
October 27-28, 2025

36th World Congress on Neurorehabilitation

Vancouver, Canada
October 29-30, 2025

5th Annual Dementia Congress

Amsterdam, Netherlands
October 30-31, 2025

34th Euro Congress on Neurologists and Psychiatrists

Paris, France
November 13-14, 2025

32nd Cognitive Neuroscience Congress

Bali, Indonesia
November 24-25, 2025

37th World Conference on Neurology

Barcelona, Spain
November 27-28, 2025

13th International Conference on Cannabis & Medicinal Research

Amsterdam, Netherlands
December 01-02, 2025

38th European Neurology Congress 2025

Vancouver, Canada
December 04-05, 2025

17th Global Neurologists Meeting on Neurology and Neurosurgery

Amsterdam, Netherlands
February 02-03, 2026

7th Global Summit on Brain Disorders and Therapeutics

Paris, France
February 12-13, 2026

8th World Conference on Neuroscience

Singapore City, Singapore
April 23-24, 2026

8th World Depression Congress

Paris, France
May 14-15, 2026

9th World Conference on Neuroscience

Rome, Italy
May 18-19, 2026

38th International conference on Mental Health and Psychiatry

Aix-en-Provence, France
June 22-23, 2026

7th World Congress on Sleep Disorders and Therapeutics

Amsterdam, Netherlands
June 29-30, 2026

37th Conference on Clinical Neuroscience and Neurogenetics

Aix-en-Provence, France

Current Research in Therapeutic Targets Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in